Skip to main content

Simcor FDA Approval History

FDA Approved: Yes (First approved February 15, 2008)
Brand name: Simcor
Generic name: niacin ER and simvastatin
Dosage form: Tablets
Company: Abbott
Treatment for: High Cholesterol

Marketing Status: Discontinued

Simcor (niacin extended-release/simvastatin) is a fixed-dose combination lipid therapy used along with diet to lower levels of total cholesterol, LDL "bad" cholesterol and triglycerides, and to increase HDL "good" cholesterol.

Development timeline for Simcor

DateArticle
Jul 29, 2010Approval Abbott's Simcor (niacin extended-release/simvastatin) Receives FDA Approval for New Dosage Strengths
Feb 19, 2008Approval Abbott Receives FDA Approval for Simcor (Niaspan / simvastatin), a Novel Combination Medicine for Comprehensive Cholesterol Management
Oct 22, 2007Abbott and Solvay Pharmaceuticals to co-promote Abbott's Simcor in the United States
Apr 20, 2007Abbott Submits New Drug Application for Simcor Combination Niaspan/Simvastatin Tablet

See also

Simcor (niacin ER and simvastatin) Consumer information

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer